Acrivon Therapeutics, Inc. financial statements
Acrivon Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 77.91M | 10-K |
| Cash and equivalents | USD 41.5M | 10-Q |
| Total debt | USD 2.71M | EODHD |
Acrivon Therapeutics, Inc. financials on 6ix · Acrivon Therapeutics, Inc. on 6ix